A Noninvasive System for Monitoring Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors with Plasma DNA-Reference-Cited by-同舟云学术

A Noninvasive System for Monitoring Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors with Plasma DNA

Published:2011-10 Issue:10 Volume:6 Page:1639-1648
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Nakamura Tomomi,Sueoka-Aragane Naoko,Iwanaga Kentaro,Sato Akemi,Komiya Kazutoshi,Abe Tomonori,Ureshino Norio,Hayashi Shinichiro,Hosomi Toshiya,Hirai Mitsuharu,Sueoka Eisaburo,Kimura Shinya

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference37 articles.

1. Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition);Bach;Chest,2007

2. Screening for epidermal growth factor receptor mutations in lung cancer;Rosell;N Engl J Med,2009

3. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR;Maemondo;N Engl J Med,2010

4. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial;Mitsudomi;Lancet Oncol,2010

5. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liquid biopsy for diagnostic and prognostic evaluation of melanoma;Frontiers in Cell and Developmental Biology;2024-08-02

2. Absence of copy number gain of EGFR : A possible predictive marker of long‐term response to afatinib;Cancer Science;2022-12-16

3. The role of comprehensive analysis with circulating tumor DNA in advanced non‐small cell lung cancer patients considered for osimertinib treatment;Cancer Medicine;2021-05-12

4. Current achievements and future perspectives with liquid biopsy;Personalized Medicine Universe;2020-10-31

5. Significance of a Liquid Biopsy on Lung Cancer;Haigan;2020-04-20